Chola Sales Leap Exclusive [upd] -

The mechanics were counterintuitive:

has reported a significant surge in its financial metrics for the third quarter of FY2026, signaling a robust "sales leap" driven by its core motor and health portfolios. Key Performance Highlights (Q3 FY2026) Gross Written Premium (GWP) : Increased to ₹2,361 crore chola sales leap exclusive

What triggered the jump? According to internal memos obtained by our team, the pivot happened 90 days ago. Chola abandoned the standard retail calendar. No more predictable "End of Season" sales. Instead, they launched the —a 72-hour, invite-only digital and in-store event tied to the Hindu solar month of Chithirai . Chola abandoned the standard retail calendar

: Chola reported a substantial revenue of ₹25,846 crore in FY25, maintaining a strong Return on Equity (ROE) of 19.8% . Exclusive Offers & Initiatives : Chola reported a substantial revenue of ₹25,846

The Chola Surge

When reached for comment, a Chola spokesperson said: “We do not comment on speculative exclusive numbers before regulatory filings. However, we reiterate that our distribution expansion and customer-centric sales initiatives have shown strong traction this quarter. The official results will be disclosed to the stock exchanges on May 5.”